FETAL PROGRAMMING OF PATHOLOGY IN ADULTS
https://doi.org/10.24884/1561-6274-2012-16-2-111-117
Abstract
The review provides data, indicating about the role of intrauterine fetal growth conditions in chronic pathology at adults and aged individuals. The significance of body mass at birth, associated with maternal nutrition, placenta, trophic status of fetus in progression of obesity, arterial hypertension and insulin resistance in postnatal period is discussed. Low body mass of fetus is associated with small number of nephrons, and with high risk of kidney diseases in adults.
About the Authors
N. N. Smirnova
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Russian Federation
Russian Federation
N. B. Kuprienko
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Russian Federation
Russian Federation
References
1. Patricia M. Quen. Carol E. Lany Handbook of Pediatric Nutrition, an Aspin Publication 1993: 560–572
2. Коровина НА, Захарова ИН, Нетребенко ОК и др. Функциональное состояние почек у детей при различных видах вскармливания. Детская гастроэнтерология и нутрициология 2005; 3 (13): 133–136
3. Дедов ИИ, Мельниченко ГА, Бутрова СА и др. Ожирение в подростковом возрасте. Результаты российского эпидемиологического исследования. Тер арх 2007; 10 (79): 28–32
4. Диагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов). Авторы (рабочая группа): ИЕ Чазова, ЛГ Ратова, СА Бойцов, ДВ Небиеридзе. Системные гипертензии 2010; 3: 5–26
5. Рязанов АС, Аракелянц АА, Юренев АП. Патогенез артериальной гипертонии в рамках метаболического синдрома. Тер арх 2003; 3 (75): 86–88
6. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 341 (1): 1077–1081
7. Stein CE, Fall CH, Kumaran K. et al. Fetal growth and coronary heart disease in south India. Lancet 1996; 348: 1269–1273
8. Leon DA, Lithell HO, Vagero D et al. Reduced fetal growth rate and increased risk of death from ischemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. Br Med J 1998; 317: 241–245
9. Huxley RR, Shiell AW. Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systemic review of the literature. J Hypertens 2000; 18: 815–831
10. Hales CN, Barker DJ, Clark PM et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019–1022
11. Barker DJ, Hales CN, Fall CH at al. Type2 (non-insulindependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993; 36: 62–67
12. Barker DJ, Winter PD, Osmond C at al. Weight in infancy and death from ischemic heart disease. Lancet 1989; 2: 577–580
13. Martyn CN, Barker DJ, Osmond C, mother’s pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet 1996; 348: 1264–1268
14. Mc Cormack VA, dos Santos Silva I, De Stavola BL at al. Fetal growth and subsequent risk of breast cancer: Result from long term follow up of Swedish cohort. BMJ 2003; 326: 248
15. Leadbitter P, Pearce N, Cheng S at al. Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax 1999; 54: 905–910
16. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293: 1089–1093
17. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004; 20: 63–68
18. Ravelli AC, Der Meulen GH, Osmond C at al. Obesity at the age of 50 in men and women exposed to famine prenatally. Am J Clin Nutr 1999; 70: 811–816
19. Vaisse C, Clement K, Durand E at al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253–262
20. King KL, Roberts CT, Sohlstrom AI at al. Chronic maternal feed restriction impairs growth but increases adiposity of the fetal guinea pig. Am J Physiol Regul Integ Comp Physiol 2005; 288: R119–126
21. Yajnik CS, Fall CH, Coyaji KJ at al. Neonatal anthropometry: the thin-fat Indian baby. The Puny Maternal Nutrition Study. Int J Obes Retard Metab Disord 2003; 27: 173–180
22. Guan H, Arany E, van Beek JP at al. Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats. Am J Physiol Endocrinol Metab 2005; 288: E663–673
23. Dispham J, Gardner DS, Gnanalingham MG at al. maternal nutritional programming of fetal adipose tissue development: Differential effects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferation-activated and prolactin receptors. Endocrinology 2005; 146: 3943–3949
24. Rennie KL, Johnson L, Jebb SA. Behavioral determinants of obesity. Best Pract Res clin Endocrinol Metab 2005; 19: 343–358
25. Desai M, Gayle D, Babu J, Ross MG. Programmed obesity in intrauterine growth-restricted newborns: Modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol 2005; 288: R91–96
26. Polkowska J, Gladysz A. Effect of food manipulation on the neuropeptide Y neuronal system in the diencephalon of ewes. J Chem Neuroanat 2001; 21: 149–159
27. Personen U, Huupponen R, Rouru J, Koulu M. hypothalamic neuropeptide expression after food restriction in Zucker rats: Evidence of persistent neuropeptide Y gene activation. Brain Res Mol Brain Res 1992; 16: 255–260
28. Kojima M, Kangawa K. Grelin: Structure and function. Physiol Rev 2005; 85: 495–522
29. Hang F, Chen Y, Heiman M, Dimarchi R. Leptin: Structure, function and biology. Vitamins & Hormones 2005; 7: 345–372
30. Korner J, Savontaus E, Chua SC at al. Leptin regulation of AgRP and NPY mRNA in the rat hypothalamus. J. Neuroendocrinol 2001; 13: 959–966
31. Dallongeville J, Hecquet B, Libel P at al. Short term response of circulating leptin to feeding and fasting in man : Influence of circadian cycle. Int J Obes Relat Metab Disord 1998; 22: 728–733
32. Roberts TJ, Caston-Balderrama A, Nijland MJ, Ross MG. Central neuropeptide Y stimulates ingestive behavior and increases urine output in the ovine fetus. Am J Physiol Endocrinol Metab 2000; 279: E494–500
33. El Haddad MA, Ismail Y, Guerra C at al. Effect of oral sucrose on ingestive behavior in the near-term ovine fetus. J Obstet Gynecol 2002; 187: 898–901
34. Ross MG, El Haddad M, Desai M at al. Unopposed orexic pathways in the developing fetus. Physiol Behav 2003; 79: 79–88
35. Davidowa H, Li Y, Plagemann A. Altered neuronal responses to feeding-relevant peptides as sign of developmental plasticity in the hypothalamic regulatory system of body weight. Zh Vyssh Nerv Deiat im I.P.Pavlova 2003; 53: 663–670
36. Mc Millen JC, Muhlhausler BS, Duffield JA, Yuen BS. Рrenatal programming of postnatal obesity: Fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proc Nutr Soc 2004; 63: 405–412
37. Eckert JE, Gatford KL, Luxford BG at al. Leptin expression in offspring is programmed by nutrition in pregnancy. J Endocrinol 2000; 165: R1–6
38. Vickers MH, Gluckman PD, Coveny AH at al. neonatal leptin treatment reverses developmental programming. Endocrinology 2005; 146: 4211–4216
39. Leslie Myatt Placental adaptive responses and fetal programming. J Physiol 2006; 572 (1): 25–30
40. Wallace JM, Aitken RP, Milne IS, & hay WW Jr Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biol Reprod 2004; 71: 1055–1062
41. Reik W, Constancia M, Fowden A at al. regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 2003; 547: 35–44
42. Mizuno Y, Sotomaru Y, Katsuzawa Y at al. Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem Biophys Res Commun 2002; 290: 1499–1505
43. Dao D, Frank D, Qian N at al. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum Mol Genet 1998; 7: 597–608
44. Welberg LA, Seckl JR & Holms MC. Inhibition of 11betahydroxysteroid dehydrogenase, the foeti-placental barrier to maternal glucocorticoidss, permanently programs amygdale GR mRNA expression and anxiety-like behaviour in the offspring. Eur J Neurosci 2000; 12: 1047–1054
45. Pepe GJ, Burch MG & Albrecht ED. Localization and developmental regulation of 11beta-hydroxysteroid dehydrogenase-1 and -2 in the baboon syncytiotrophoblast. Endocrinology 2001; 142: 68–80
46. Charnock-Jones DS, Kaufmann P & Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis, 1. Molecular regulation. Placenta 2004; 25:103–113
47. Kaufmann P, Mayhew TM & Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. Changes during normal pregnancy. Placenta 2004; 25: 114–126
48. Woods LL, Weeks DA. Naturally occurring intrauterine growth retardation and adult blood pressure in rats. Pediatric Res 2004; 56: 763–767
49. Ross MG, Desai M, Guerra C, Wang S. programmed syndrome of hypernatremic hypertension in ovine twin lambs. Am J Obstet Gynecol 2005; 192:1196–1204
50. Lewis RM, Forhead AJ, Petry CJ at al. long-term programming of blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Br J Nutr 2002; 88: 283–290
51. Jackson AA, Dunn RL, Marchand MC, Langley-Evans SC Increased systolic blood pressure in rats induced by maternal lowprotein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond) 2002; 103: 633–639
52. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systemic review of the literature. J Hypertens 2000: 18: 815–831
53. Christensen K, Vaupel JW, Holm NV, Yashin AI. Mortality among twins after age 6: foetal origins hypothesis versus twin method. Br Med J 1995; 310: 432–436
54. Keijzer-Veen MG, Finken MJ, Nauta J at al. Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in the Netherlands. Pediatrics 2005; 116: 725–731
55. Schluchter MD. Publication bias and heterogeneity in the relationship between systolic blood pressure, birth weight and catch-up growth – a meta- analysis. J Hypertens 2003; 21: 273–279
56. Valerie A. Luyckx & Barry M. Brenner Low birth weight, nephron number, and kidney disease. Kidney International 2005; 68 [Suppl 97]: S68–S77
57. Leeson CP, Kattenhorn M, Morley R at al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001; 103: 1264–1268
58. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 75: 346–359
59. Johnston LB, Dahlgren J, Leger J at al. Association between insulin-like growth factor 1 (IGF-1) polymorphisms, circulating IGF-1, and pre- and postnatal growth in two European small for gestation age populations. J Clin Endocrinol Metab 2003; 88: 4805–4810
60. Jensen RB, Chellakooty M, Vielwerth S at al. Intrauterine growth retardation and consequence for endocrine and cardiovascular disease in adult life: does insuline-like growth factor play a role? Horm Res 2003; 60[Suppl 3]: 136–148
61. Ricardo Sesso & maria C.P Franco. Abnormalities in Metalloproteinase pathways and IGF-1 Axis: a Link between Birth Weight, Hypertension, and Vascular Damage in Childhood. American journal of hypertension 2010; 23 (1): 6–11
62. Day IN, Chen XH, Gaunt TR at al. Late life metabolic syndrome, early growth and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 2004; 89: 5569–5576
63. Klebanoff MA, Graubard BI, Kessel SS, Berendes HW. Lowbirth weight across generations. JAMA 1984; 252: 2423–2427.
64. Stein AD, Lumey LH. The relationship between maternal and offspring birth weights after maternal prenatal famine exposure: the Dutch Famine Birth Cohort Study. Hum Biol 2000; 72: 641–654
65. Ibanez L, Potau N, Enriquez G, de Zegher F. Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res 2000; 47: 575–577
66. Reik W, Santos F, Dean W. Mammalian epigenomics: reprogramming the genome for development and therapy. Theriogenology 2003; 59: 21–32
67. Harding JE, Bloomfield FH. Prenatal treatment of intrauterine growth restriction: lessons from the sheep model. Pediatr Endocrinol Rev 2004; 2: 182–192
68. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Foetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol 2000; 279: E83–E87
69. Vickers MH, Breier BH, McCarthy D, Gluckman PD. Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol 2003; 285: R271–R273
70. Vickers MH, Gluckman PD, Coveny AH et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 2005; 146: 4211–4216
Review
For citations:
Smirnova N.N., Kuprienko N.B. FETAL PROGRAMMING OF PATHOLOGY IN ADULTS. Nephrology (Saint-Petersburg). 2012;16(2):111-117. (In Russ.) https://doi.org/10.24884/1561-6274-2012-16-2-111-117
Views:
368
Email this article 